Drug Metabolism Reactions Flashcards
Drug-metabolizing enzymes have _____ substrates and play role in normal metabolism.
endogenous
Nonresponse to antidepressants has been reported in ______ UMs.
CYP2D6
______ is a detoxifying process involving formation of readily excreted metabolites that are pharmacologically inactive.
Drug metabolism
Individual patients can vary in enzyme activity and can be classified at the extremes as ______ or ______ with total absence of enzyme.
ultra-rapid (UM) metabolizers; poor metabolizers (PM)
______ has been reported in CYP2D6 UMs.
Nonresponse to antidepressants
_____ are generally converted to more water-soluble (more polar) compounds that are then more readily excreted.
Lipid-soluble compounds
Insufficient analgesia with codeine is seen in CYP2D6 _____ due to failure to metabolize to the active metabolite, morphine.
PMs
Drug metabolism is a ______ involving formation of readily excreted metabolites that are pharmacologically inactive.
detoxifying process
Hydrolysis of some _______ by intestinal bacterial enzymes (β-glucuronidase) results in the formation of _____.
glucuronides; free drug
What is N-Acetylation?
amide bond formation via N-acetyltransferases
_____ enzymes are present in plasma, liver, and other tissues.
Esterases
______ are microsomal enzymes present in liver, kidney, GI tract.
Glucuronyl transferases
Glucuronyl transferases are microsomal enzymes present in the ____, _____, and _____.
liver, kidney, GI tract
Glutathione-S-transferases have a limited role in drug metabolism but are extremely important in detoxification of _____, ______, and _______.
carcinogens; pollutants; toxic metabolites
Oxidation is a _____ metabolic reaction.
phase I
Sulfate conjugation results in formation of strong acids with a pKa of _____.
1
What is the product of a conjugation reaction?
a highly water-soluble, readily excreted product
In N-acetylation, the acetyl group is donated by _____.
acetyl CoA
______ of PPIs for peptic ulcers is seen in CYP2C19 PMs.
Decreased efficacy
Where are amidases found?
liver and gut flora
Name a drug that, when metabolized, can create a toxic metabolite.
acetaminophen (to N-Acetyl-benzoquinoneimine)
Increased ______ is seen in patients with CYP2D6 activity PMs.
antipsychotic drug toxicity
_____ hydrolyze esters to corresponding alcohol and acid.
Esterases
In _____, an amide bond is formed via N-acetyltransferases.
N-acetylation
______ have endogenous substrates and play role in normal metabolism.
Drug-metabolizing enzymes
What 2 isozymes account for 25% of drug metabolism?
CYP2D6 and CYP2C19
______ of some glucuronides by ______ (β-glucuronidase) results in the formation of free drug.
Hydrolysis; intestinal bacterial enzymes
Which phase I reduction can produce toxic intermediates?
nitro reduction
Give 2 examples of drugs that, when metabolized, are more active.
1) codeine (to morphine) 2) hydrocodone (to hydromorphone)
Codeine intoxication is seen in _____ UMs due to rapid metabolism to morphine.
CYP2D6
What is the postnatal development of the cytochrome P-450-dependent oxidation?
variable; usu neonates are 50-75% of adult levels, but some drugs are metabolized faster
Most drugs undergo ______ after administration to the patient.
enzyme-catalyzed chemical structure transformation
Increased antipsychotic drug toxicity in patients with CYP2D6 activity ______.
PMs
Increased antipsychotic drug toxicity is seen in patients with _____ activity PMs.
CYP2D6
What is Enterohepatic recirculation?
when the drug is secreted by the liver into bile as a drug-conjugate and then reabsorbed via the GI tract as a free drug
Which reactions do phase I transformations include?
oxidation, reduction, hydrolysis
What do CYP450 enzymes do?
catalyze oxidation in the smooth ER
The coenzyme donor of sulfate is _____.
PAPS
Cytochrome P450 is part of an oxidation system that also includes the cofactor NADPH, the flavoprotein NADPH-cytochrome P450 reductase, and ______.
molecular O2
Name an important enzyme in neurotransmitter metabolism.
monoamine oxidase
What is vitamin K reductase (VKORC1)?
the enzyme target of warfarin